rs61750615
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. BS1BP5PP4
This summary comes from the ClinGen Evidence Repository: NM_000552.5(VWF):c.6187C>T is a missense variant that replaces proline with serine at position 2063. The Grpmax filtering allele frequency in gnomAD v4.1 is 0.04661 (based on 4353/91066 alleles in the South Asian population, with 145 homozygotes), which is higher than the ClinGen VWD VCEP BS1 threshold of >0.01 (BS1). At least 1 proband harboring the variant in the homozygous state exhibits a history of severe bleeding and a quantitative defect in VWF, consistent with VWD Type 3 (PMID:23354996), however, it is not yet clear whether this phenotype is sufficiently specific to meet PP4. While this variant is also reported to be present in the homozygous state in multiple other affected probands (PMID:23354996), PS4 cannot be considered because BS1 is met. The recombinant p.Pro2063Ser variant in COS-7 cells matches properties of the wild-type recombinant protein, including normal expression, secretion, and multimer formation, inconsistent with a quantitative defect relevant to VWD Type 3 (PMID:19566550). BS3_Supporting is not met because this criterion is considered not applicable to this gene-disease relationship. This variant has been observed in affected cases with an alternate molecular basis for disease, including in VWD Type 3 in cis with either the NM_000552.5(VWF):c.970C>T (p.Arg324Ter) variant (PMID:33550700) or the NM_000552.5(VWF):c.5200C>T (p.Gln1734Ter) variant (PMID:23702511). Both comparison variants have been classified as Pathogenic by the ClinGen VWD VCEP. Three other reported cases with diverse VWD diagnoses harbor this variant as well as a second variant in VWF (PMID:19404524, PMID:21534937, PMID:16985174), however, the comparison variants have not yet been classified by the ClinGen VWD VCEP. In summary, this variant meets the criteria to be classified as Likely Benign for hereditary von Willebrand disease based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD VCEP: BS1, BP5, PP4. (VCEP Rule specifications for von Willebrand disease type 2A, 2B and 2M v1.0.0; date of approval 08/13/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA202650/MONDO:0019565/090
Frequency
Consequence
NM_000552.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary von Willebrand diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- von Willebrand disease type 2BInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- von Willebrand disease 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- von Willebrand disease 1Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- von Willebrand disease type 2AInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- von Willebrand disease type 2MInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- von Willebrand disease 3Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- von Willebrand disease type 2NInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00748 AC: 1139AN: 152172Hom.: 16 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0126 AC: 3178AN: 251442 AF XY: 0.0149 show subpopulations
GnomAD4 exome AF: 0.0103 AC: 15042AN: 1461852Hom.: 192 Cov.: 32 AF XY: 0.0118 AC XY: 8580AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00747 AC: 1137AN: 152290Hom.: 16 Cov.: 31 AF XY: 0.00777 AC XY: 579AN XY: 74474 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:4Other:1
VWF: BS1, BS2 -
- -
- -
- -
- -
Hereditary von Willebrand disease Uncertain:1Benign:2
- -
- -
NM_000552.5(VWF):c.6187C>T is a missense variant that replaces proline with serine at position 2063. The Grpmax filtering allele frequency in gnomAD v4.1 is 0.04661 (based on 4353/91066 alleles in the South Asian population, with 145 homozygotes), which is higher than the ClinGen VWD VCEP BS1 threshold of >0.01 (BS1). At least 1 proband harboring the variant in the homozygous state exhibits a history of severe bleeding and a quantitative defect in VWF, consistent with VWD Type 3 (PMID: 23354996), however, it is not yet clear whether this phenotype is sufficiently specific to meet PP4. While this variant is also reported to be present in the homozygous state in multiple other affected probands (PMID: 23354996), PS4 cannot be considered because BS1 is met. The recombinant p.Pro2063Ser variant in COS-7 cells matches properties of the wild-type recombinant protein, including normal expression, secretion, and multimer formation, inconsistent with a quantitative defect relevant to VWD Type 3 (PMID: 19566550). BS3_Supporting is not met because this criterion is considered not applicable to this gene-disease relationship. This variant has been observed in affected cases with an alternate molecular basis for disease, including in VWD Type 3 in cis with either the NM_000552.5(VWF):c.970C>T (p.Arg324Ter) variant (PMID: 33550700) or the NM_000552.5(VWF):c.5200C>T (p.Gln1734Ter) variant (PMID: 23702511). Both comparison variants have been classified as Pathogenic by the ClinGen VWD VCEP. Three other reported cases with diverse VWD diagnoses harbor this variant as well as a second variant in VWF (PMID: 19404524, PMID: 21534937, PMID: 16985174), however, the comparison variants have not yet been classified by the ClinGen VWD VCEP. In summary, this variant meets the criteria to be classified as Likely Benign for hereditary von Willebrand disease based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD VCEP: BS1, BP5, PP4. (VCEP Rule specifications for von Willebrand disease type 2A, 2B and 2M v1.0.0; date of approval 08/13/2024) -
not specified Benign:3
- -
- -
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -
von Willebrand disease type 1 Benign:2
- -
- -
von Willebrand disease type 2 Benign:1
- -
von Willebrand disease type 3 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at